Leone Andrew R, Kidd Laura C, Diorio Gregory J, Zargar-Shoshtari Kamran, Sharma Pranav, Sexton Wade J, Spiess Philippe E
Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive Office 12538, Tampa, FL, 33612, USA.
BMC Urol. 2017 Jan 12;17(1):6. doi: 10.1186/s12894-016-0190-2.
The goal was to assess the natural history and management of patients with pathologically proven bilateral (synchronous) RO after undergoing initial partial nephrectomy (PN).
All patients underwent either robotic/laparoscopic or open PN by two experienced genitourinary oncologists from 2005-2013. Final pathology was determined by surgical excision, CT-guided percutaneous core biopsy (CT-biopsy) or fine needle aspiration (FNA). Patient demographics, tumor characteristics (pathologic data, location, size) type of surgery, pre/post estimated glomerular filtration rate (eGFR) and surgical complications were recorded.
Twelve patients were identified with bilateral RO. Median age at the time of surgery was 68 years (46-77) (Table 1). The median size of the largest tumor(s) resected was 2.75 cm (1.5-5.5 cm) and second largest tumor(s) was 1.75 cm (1.0-4.0 cm). Four patients underwent bilateral staged PN and one patient underwent simultaneous bilateral PN (horseshoe kidney). Two patients underwent RFA at the time of biopsy of the contralateral mass after PN. Five patients underwent CT-bx/FNA (5/5) of the contralateral mass followed by active surveillance. Mean follow up was 34 months. There was no significant change in median creatinine pre- and post-operatively. One patient was lost to follow up and one patient died of unknown causes 5 years post-operatively. eGFR decreased an average of 16.96% post-operatively, including a single patient whose eGFR increased by 7.8% after surgery and a single patient whose eGFR did not change (Table 2).
Patients with bilateral renal masses and pathologically proven RO can be safely managed with active surveillance after biopsy confirmation of the contralateral mass.
目的是评估经病理证实为双侧(同时性)肾嗜酸细胞瘤(RO)患者在接受初次部分肾切除术(PN)后的自然病史及治疗情况。
2005年至2013年期间,由两位经验丰富的泌尿生殖肿瘤学家对所有患者实施机器人/腹腔镜或开放性PN。最终病理通过手术切除、CT引导下经皮穿刺活检(CT活检)或细针穿刺抽吸(FNA)确定。记录患者人口统计学资料、肿瘤特征(病理数据、位置、大小)、手术类型以及术前/术后估计肾小球滤过率(eGFR)和手术并发症。
共确定12例双侧RO患者。手术时的中位年龄为68岁(46 - 77岁)(表1)。切除的最大肿瘤的中位大小为2.75 cm(1.5 - 5.5 cm),第二大肿瘤为1.75 cm(1.0 - 4.0 cm)。4例患者接受双侧分期PN,1例患者接受同期双侧PN(马蹄肾)。2例患者在PN后对侧肿块活检时接受射频消融(RFA)。5例患者对侧肿块接受CT活检/FNA(5/5),随后进行主动监测。平均随访34个月。术前和术后肌酐中位数无显著变化。1例患者失访,1例患者术后5年死于不明原因。术后eGFR平均下降16.96%,其中1例患者术后eGFR升高7.8%,1例患者eGFR无变化(表2)。
经病理证实为双侧肾肿块且为RO的患者,在对侧肿块活检确认后,可通过主动监测安全管理。